Akso Health (AHG) Invested Capital (2017 - 2025)
Akso Health (AHG) has disclosed Invested Capital for 7 consecutive years, with $138.4 million as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Invested Capital rose 1486.47% year-over-year to $138.4 million, compared with a TTM value of $138.4 million through Mar 2024, up 1486.47%, and an annual FY2024 reading of $138.4 million, up 1486.47% over the prior year.
- Invested Capital was $138.4 million for Q1 2024 at Akso Health, up from $8.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $138.4 million in Q1 2024 and bottomed at $8.7 million in Q1 2023.
- Average Invested Capital over 5 years is $53.4 million, with a median of $49.5 million recorded in 2022.
- The sharpest move saw Invested Capital crashed 82.37% in 2023, then skyrocketed 1486.47% in 2024.
- Year by year, Invested Capital stood at $50.2 million in 2020, then crashed by 59.68% to $20.2 million in 2021, then surged by 144.49% to $49.5 million in 2022, then crashed by 82.37% to $8.7 million in 2023, then surged by 1486.47% to $138.4 million in 2024.
- Business Quant data shows Invested Capital for AHG at $138.4 million in Q1 2024, $8.7 million in Q1 2023, and $49.5 million in Q1 2022.